Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 12, 2021 16:10 ET | Source: Adicet Bio

Adicet Announces Promotion of Blake Aftab, Ph.D. to Chief Scientific Officer

MENLO PARK, Calif. and BOSTON, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell...
October 04, 2021 07:00 ET | Source: Adicet Bio

Adicet to Present Preclinical Data from Allogeneic Gamma Delta T Cell Platform at SITC 36th Annual Meeting

MENLO PARK, Calif. and BOSTON, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell...
September 13, 2021 08:00 ET | Source: Adicet Bio

Adicet Bio Collaborates with Twist Bioscience to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics

MENLO PARK, Calif., and BOSTON, MA, and SOUTH SAN FRANCISCO, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing...
September 02, 2021 16:53 ET | Source: Adicet Bio

Adicet Bio to Participate in Upcoming Investor Conferences

MENLO PARK, Calif. and BOSTON, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for...
August 12, 2021 16:01 ET | Source: Adicet Bio

Adicet Reports Second Quarter 2021 Financial Results and Provides Business Updates

MENLO PARK, Calif. and BOSTON, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell...
August 02, 2021 07:00 ET | Source: Adicet Bio

Adicet Bio to Participate in Upcoming Investor Conferences

MENLO PARK, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other...
July 15, 2021 07:00 ET | Source: Adicet Bio

Adicet Bio Announces Formation of Scientific Advisory Board

MENLO PARK, Calif and BOSTON, July 15, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer...
June 28, 2021 07:00 ET | Source: Adicet Bio

Adicet Bio Added to the Russell 2000® Index

MENLO PARK, Calif. and BOSTON, June 28, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for...
May 18, 2021 16:10 ET | Source: Adicet Bio

Adicet Bio to Participate in Upcoming Investor Conferences

MENLO PARK, Calif., May 18, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other...
May 17, 2021 07:01 ET | Source: Adicet Bio

Adicet Reports First Quarter 2021 Financial Results and Provides Business Updates

Initiated Phase 1 Trial of ADI-001 for the Treatment of B Cell Non-Hodgkin's Lymphoma (NHL), interim clinical data expected in late 2021 Successfully raised $143.8 million in net proceeds through a...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right